A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma
Status:
Completed
Trial end date:
2013-11-12
Target enrollment:
Participant gender:
Summary
To compare the efficacy of oral CC-5013 in combination with oral pulse high-dose
dexamethasone to that of placebo and oral high-dose pulse dexamethasone as treatment for
subjects with relapsed or refractory multiple myeloma."